Showing 1 - 12 results of 12 for search 'Xiao-wen Tang', query time: 0.06s Refine Results
  1. 1
    Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study

    Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study by Xin-Yu Zhuang, Zheng-Tai Sun, Yue Xu, Ya-Ru Ren, Ying-Jie Chen, Feng Chen, Feng Chen, Xiao Ma, Xiao Ma, Xiao-Wen Tang, Xiao-Wen Tang, Xiao-Feng Zhang, Xiao-Feng Zhang

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Corneal perforation associated with ocular graft-versus-host disease

    Corneal perforation associated with ocular graft-versus-host disease by Yue Xu, Ying-Ming Wang, Zheng-Tai Sun, Xiao-Long Yang, Xin-Yu Zhuang, Ya-Ru Ren, Ying-Jie Chen, Ying-Jie Chen, Feng Chen, Feng Chen, Xiao Ma, Xiao Ma, Xiao-Wen Tang, Xiao-Wen Tang, Xiao-Feng Zhang

    Published 2022-09-01
    Get full text
    Article
  3. 3
    Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion

    Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion by Hai-Ping Dai, Hai-Ping Dai, Hai-Ping Dai, Jia Yin, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Zheng Li, Chun-Xiao Yang, Tin Cao, Ping Chen, Yun-Hui Zong, Ming-Qing Zhu, Ming-Qing Zhu, Ming-Qing Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Sheng Xiao, De-Pei Wu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang, Xiao-Wen Tang

    Published 2020-03-01
    Get full text
    Article
  4. 4
    CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

    CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL by Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang

    Published 2023-02-01
    Get full text
    Article
  5. 5
    Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma

    Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma by Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang

    Published 2022-02-01
    Get full text
    Article
  6. 6
    Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia

    Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia by Xin-Yue Zhang, Xin-Yue Zhang, Hai-Ping Dai, Hai-Ping Dai, Zheng Li, Zheng Li, Jia Yin, Jia Yin, Xing-Ping Lang, Chun-Xiao Yang, Sheng Xiao, Ming-Qing Zhu, Ming-Qing Zhu, Dan-Dan Liu, Dan-Dan Liu, Hong Liu, Hong Liu, Hong-Jie Shen, Hong-Jie Shen, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang

    Published 2021-01-01
    Get full text
    Article
  7. 7
    Physiological and transcriptome analysis of Mytilus coruscus in response to Prorocentrum lima and microplastics

    Physiological and transcriptome analysis of Mytilus coruscus in response to Prorocentrum lima and microplastics by Xiao-wen Tang, Rong Yu, Mei-hua Fan, Zhi Yang, Zhi Liao, Zong-xin Yang, Chen-ying Xie, Yu-kun Xuan, Jian-xin Wang, Xiao-lin Zhang, Xiao-jun Yan

    Published 2022-12-01
    Get full text
    Article
  8. 8
    Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia

    Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia by Jun-Feng Zhu, Jun-Feng Zhu, Jun-Feng Zhu, Hai-Ping Dai, Hai-Ping Dai, Qian-Qian Zhang, Qian-Qian Zhang, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Qin-Ya Cui, Qin-Ya Cui, Xiao-Peng Tian, Xiao-Peng Tian, Si-Ning Liu, Si-Ning Liu, Zheng-Ming Jin, Zheng-Ming Jin, Xia-Ming Zhu, Xia-Ming Zhu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang

    Published 2022-10-01
    Get full text
    Article
  9. 9
    Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study

    Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study by Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai

    Published 2023-11-01
    Get full text
    Article
  10. 10
    Impact of FLT3-ITD length on prognosis of acute myeloid leukemia

    Impact of FLT3-ITD length on prognosis of acute myeloid leukemia by Song-Bai Liu, Hao-Jie Dong, Xie-Bing Bao, Qiao-Cheng Qiu, Hong-Zhi Li, Hong-Jie Shen, Zi-Xuan Ding, Chao Wang, Xiao-Ling Chu, Jing-Qiu Yu, Tao Tao, Zheng Li, Xiao-Wen Tang, Su-Ning Chen, De-Pei Wu, Ling Li, Sheng-Li Xue

    Published 2019-01-01
    Get full text
    Article
  11. 11
    The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

    The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update by Xiao-hui Zhang, Jing Chen, Ming-Zhe Han, He Huang, Er-lie Jiang, Ming Jiang, Yong-rong Lai, Dai-hong Liu, Qi-Fa Liu, Ting Liu, Han-yun Ren, Yong-Ping Song, Zi-min Sun, Xiao-wen Tang, Jian-min Wang, De-pei Wu, Lan-ping Xu, Xi Zhang, Dao-bin Zhou, Xiao-jun Huang

    Published 2021-09-01
    Get full text
    Article
  12. 12
    Safe and potent anti‐CD19 CAR T‐cells with shRNA‐IL‐6 gene silencing element in patients with refractory or relapsed B‐cell acute lymphoblastic leukemia

    Safe and potent anti‐CD19 CAR T‐cells with shRNA‐IL‐6 gene silencing element in patients with refractory or relapsed B‐cell acute lymphoblastic leukemia by Jin‐Feng Ma, Jia‐Wei Yan, Mei‐Jing Liu, Chun‐Long Yan, Xiao‐Wen Tang, Hui‐Ying Qiu, Miao Miao, Yue Han, Li‐Min Li, Li‐Qing Kang, Nan Xu, Zhou Yu, Jing‐Wen Tan, Hong‐Jia Zhu, Xu Jia, Zhi‐Zhi Zhang, Miao Wang, Hai‐Ping Dai, Lei Yu, Sheng‐Li Xue, De‐Pei Wu, Wen‐Jie Gong

    Published 2024-10-01
    Get full text
    Article

Search Tools: